Pro­bi­otic risks

Pharmacy Daily - - News -

JUST be­cause a la­bel on a bot­tle of pro­bi­otic sup­ple­ments has some de­tails around the live or­gan­isms in­cluded with es­ti­mated num­bers per cap­sule, health pro­fes­sion­als can­not as­sume the in­for­ma­tion is ad­e­quate to as­sure con­sumers of a pos­i­tive risk-ben­e­fit ra­tio, ac­cord­ing to an ar­ti­cle pub­lished in JAMA In­ter­nal Medicine this month.

Somerville Hospi­tal Pri­mary Care physi­cian Pi­eter A Co­hen wrote that iden­ti­fy­ing and elim­i­nat­ing po­ten­tially trans­ferrable an­tibi­otic re­sis­tance genes for all bac­te­rial strains prior to mar­ket­ing should be man­dated by the US Food and Drug Ad­min­is­tra­tion (FDA), as is al­ready re­quired in Canada.

Co­hen chal­lenged the FDA’s “un­der­de­vel­oped reg­u­la­tory frame­work” - ja­manet­work.com.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.